{"status":"OK","data":{"advertisement":{"id":356764,"title":"REQUEST FOR QUOTATION No 16 03 2026 J: - Peptide Synthesis Service: JAG1 (188-204)","partial_offer_allowed":false,"publication_date":"2026-03-23","submission_deadline":"2026-03-24 23:59:59","planned_sign_date":"2026-03-01","supplementary_orders":null,"terms_of_contract_change":"Warunki zmiany umowy zosta\u0142y zamieszone w za\u0142\u0105czonym zapytaniu ofertowym w wersji PDF.\nThe terms and conditions of the contract amendment are set out in the attached PDF version of the RFQ.","created_at":"2026-03-23 08:48:24","modified_at":"2026-03-25 00:01:10","contact_persons":[{"id":57,"forename":"Aleksandra","surname":"Mazga\u0142a","phone_number":"+48 538 899 945","email":"tenders@ryvu.com","created_by":null,"created_at":"2026-11-06 17:43:17","modified_at":"2026-11-06 17:43:17","modified_by":null}],"orders":[{"id":576970,"estimated_value":null,"order_items":[{"id":649806,"description":"Sporz\u0105dzanie i dostawa na \u017c\u0105danie peptydu JAG-1 (188-204), peptydu DSL, w jednostkach po 1 mg, w \u0142\u0105cznej ilo\u015bci od 50 \u00d7 1 mg do 250 \u00d7 1 mg, zamawianych w ramach zam\u00f3wie\u0144 cz\u0105stkowych do dnia 31 grudnia 2027.\nSyntezowany peptyd musi spe\u0142nia\u0107 nast\u0119puj\u0105ce specyfikacje:\n\nNazwa: JAG1 (188-204) DSL peptide\nSekwencja: H CDDYYYGFGCNKFCRPR OH\nSekwencja w kodzie trzy-literowym: H-Cys-Asp-Asp-Tyr-Tyr-Tyr-Gly-Phe-Gly-Cys-Asn-Lys-Phe-Cys-Arg-Pro-Arg-OH\nPochodzenie: ludzkie\nWz\u00f3r chemiczny: C93H127N25O26S3\nMasa cz\u0105steczkowa: 2107.5 Da (\u00b1 0.2%)\nCzysto\u015b\u0107: \u226595% wg HPLC\nKonigacja: brak koniugacji\nForma produktu ko\u0144cowego: liofilizowany bia\u0142y proszek\nIlo\u015b\u0107 na jednostk\u0119 us\u0142ugi: 1 mg\nZakres w ramach umowy: od 50 \u00d7 1 mg do 250 \u00d7 1 mg\n\nUs\u0142uga b\u0119dzie \u015bwiadczona w na \u017c\u0105danie, inicjowanym poprzez indywidualne zapotrzebowania zakupowe.\n\u0141\u0105czna liczba zamawianych jednostek syntezy w trakcie obowi\u0105zywania umowy wynosi\u0107 b\u0119dzie od 50 do 250 jednostek (po 1 mg ka\u017cda).\nWykonawca pozostaje w gotowo\u015bci do realizacji us\u0142ugi do dnia 31 grudnia 2027, z mo\u017cliwo\u015bci\u0105 przed\u0142u\u017cenia w zale\u017cno\u015bci od aktualizacji umowy o dofinansowanie Projektu.\n\n***\n\nOn\u2011demand synthesis and delivery of the peptide JAG\u20111 (188\u2011204), DSL Peptide, in unit quantities of 1 mg, for a total volume ranging from 50 \u00d7 1 mg up to 250 \u00d7 1 mg, ordered through call\u2011off orders until 31st December 2027.\n\nThe synthesized peptide must meet the following specifications:\nName: JAG1 (188-204) DSL peptide\nSequence: H CDDYYYGFGCNKFCRPR OH\nSequence three letter code: H-Cys-Asp-Asp-Tyr-Tyr-Tyr-Gly-Phe-Gly-Cys-Asn-Lys-Phe-Cys-Arg-Pro-Arg-OH\nOrigin: human\nMolecular Formula: C93H127N25O26S3\nMolecular Weight: 2107.5 Da (\u00b1 0.2%)\nPurity: \u226595% by HPLC\nConjugation: Unconjugated\nForm of final deliverable: Lyophilized white powder\nQuantity per service unit: 1 mg\nScope per contract: From 50 \u00d7 1 mg to 250 \u00d7 1 mg.\n\nThe service will be provided on a call off (on demand) basis, initiated by individual purchase requests. \nThe total volume requested throughout the contract term may range from 50 to 250 synthesis units (1 mg each). \nThe Contractor shall remain ready to perform the service until 31st December 2027, with a possible extension depending on updates to the Project co financing agreement.\n","warranty_period":null,"cpv_items":[{"id":8515,"code":"73111000-3","name":"Laboratoryjne us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2026-03-23 08:48:24","modified_at":"2026-03-23 08:51:42","modified_by":null,"id":738801,"type":{"id":1,"name":"adres"},"group_uuid":"12ca4753-265b-482b-942c-719c15b2b1bc"}],"participation_conditions":[{"id":1851897,"description":"Pe\u0142na lista warunk\u00f3w udzia\u0142u w post\u0119powaniu znajduj\u0119 si\u0119 w za\u0142\u0105czonym zapytaniu ofertowym w wersji PDF.\nThe full list of conditions for participation in the proceedings can be found in the attached PDF version of the request for quotation.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2026-03-23 08:48:24","modified_at":"2026-03-23 08:48:24","modified_by":null,"group_uuid":"e8888322-4603-443b-a2ec-164ff711cf59"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2026-03-23 08:48:24","modified_at":"2026-03-23 08:51:42","modified_by":null,"group_uuid":"16ef92e2-fa87-43e4-be31-d7d4d791475c"}],"evaluation_criteria":[{"id":1037923,"price_criterion":true,"description":"Cena netto - waga: 100%\nNet price - weight: 100%","created_by":null,"created_at":"2026-03-23 08:48:24","modified_at":"2026-03-23 08:48:24","modified_by":null,"group_uuid":"746115f8-26f0-4ab2-9bdb-94466d414790"}],"is_variant":false,"title":"JAG1","order_node":{"id":434776},"created_by":null,"created_at":"2026-03-23 08:48:24","modified_at":"2026-03-23 08:51:42","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":{"id":112,"contact_persons":[]},"created_at":"2026-03-23 08:48:24","modified_at":"2026-03-23 08:48:24","modified_by":{"id":112,"contact_persons":[]},"id":1003994,"street":"Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2026-03-23 08:48:24","modified_at":"2026-03-23 08:48:24","modified_by":{"id":112,"contact_persons":[]},"id":357732},"advertisement":{"id":269330,"number":"2026-112-269330","publication_date":"2026-03-16","created_by":{"id":112,"contact_persons":[]},"created_at":"2026-03-16 13:51:56","modified_at":"2026-03-25 00:01:10","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[355343,355347,356764],"enrollment":null,"projects":[{"id":46698,"name":"\"ONCO Prime: nowe mo\u017cliwo\u015bci personalizowanej terapii przeciwnowotworowej w oparciu o hodowl\u0119 kom\u00f3rek pierwotnych od pacjenta, charakteryzacj\u0119 omiczn\u0105 i testy funkcjonalne\"","number":"0095/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.02-0095/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":112,"contact_persons":[]},"created_at":"2024-06-07 14:14:14","modified_at":"2024-06-07 14:14:14","modified_by":{"id":112,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":355347,"publication_date":"2026-03-16"},"id":2395698,"name":"RFQ 16 03 2026 J.pdf","file":{"id":2660630,"name":"RFQ 16 03 2026 J.pdf","created_at":"2026-03-23 08:48:24","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/2660630"},"group_uuid":"be9a44bc-0bfa-48d4-9a21-24e6a9b1a337"},{"origin":{"id":355347,"publication_date":"2026-03-16"},"id":2395699,"name":"Offer Form 16 03 2026 J.docx","file":{"id":2660631,"name":"Offer Form 16 03 2026 J.docx","created_at":"2026-03-23 08:48:24","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/2660631"},"group_uuid":"91957135-6661-484d-9e6f-2ff956bab157"},{"origin":{"id":356764,"publication_date":"2026-03-23"},"id":2410998,"name":"RFQ 16 03 2026 J - update 23.03.2026.pdf","file":{"id":2677431,"name":"RFQ 16 03 2026 J - update 23.03.2026.pdf","created_at":"2026-03-23 08:51:34","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/2677431"},"group_uuid":"d5e5d0da-2da1-4888-99b9-45622ef2a971"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}